LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-edge Drug Discovery SyntheX leverages synthetic biology for innovative drug discovery platforms, offering potential partnerships for companies seeking advanced solutions in the biotechnology research field.

Targeted Oncology Therapies With a focus on oncology in their lead programs, SyntheX presents a strong opportunity for collaboration with organizations interested in developing targeted therapies for cancer treatment.

Financially Stable Startup Despite being a startup, SyntheX has secured $5.2M in funding and falls within the revenue range of $0 - $10M, indicating financial stability and potential for investment or partnership.

Efficient Drug Selection Process Using intracellular drug selection and DNA-encoded libraries, SyntheX offers a unique and efficient approach to molecule production, which can be appealing to companies looking for streamlined drug discovery processes.

Tech-savvy Operations Employing technologies like React and Webpack, SyntheX demonstrates a tech-savvy approach in their operations, making them an attractive partner for companies seeking cutting-edge solutions in biotechnology research.

SyntheX Tech Stack

SyntheX uses 8 technology products and services including Google Analytics, Wix, RequireJS, and more. Explore SyntheX's tech stack below.

  • Google Analytics
    Analytics
  • Wix
    Content Management System
  • RequireJS
    Javascript Frameworks
  • React
    Javascript Frameworks
  • TweenMax
    Javascript Frameworks
  • Polyfill
    Javascript Libraries
  • Webpack
    Miscellaneous
  • Bootstrap
    UI Frameworks

SyntheX's Email Address Formats

SyntheX uses at least 1 format(s):
SyntheX Email FormatsExamplePercentage
FLast@synthexlabs.comJDoe@synthexlabs.com
50%
FLast@synthexlabs.comJDoe@synthexlabs.com
50%

Frequently Asked Questions

Where is SyntheX's headquarters located?

Minus sign iconPlus sign iconSyntheX's main headquarters is located at 409 Illinois St San Francisco, California 94158 US. The company has employees across 2 continents, including North AmericaEurope.

What is SyntheX's phone number?

Minus sign iconPlus sign icon You can contact SyntheX's main corporate office by phone at +1-415-706-8701. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SyntheX's official website and social media links?

Minus sign iconPlus sign iconSyntheX's official website is synthexlabs.com and has social profiles on LinkedIn.

How much revenue does SyntheX generate?

Minus sign iconPlus sign icon As of September 2024, SyntheX's annual revenue reached $3.8M.

What is SyntheX's SIC code NAICS code?

Minus sign iconPlus sign iconSyntheX's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SyntheX have currently?

Minus sign iconPlus sign iconAs of September 2024, SyntheX has approximately 25 employees across 2 continents, including North AmericaEurope. Key team members include Head Of Discovery Platforms: R. B.Head Of Discovery Platforms: R. B.Head Of Peptide Chemistry: D. S. N.. Explore SyntheX's employee directory with LeadIQ.

What industry does SyntheX belong to?

Minus sign iconPlus sign iconSyntheX operates in the Biotechnology Research industry.

What technology does SyntheX use?

Minus sign iconPlus sign iconSyntheX's tech stack includes Google AnalyticsWixRequireJSReactTweenMaxPolyfillWebpackBootstrap.

What is SyntheX's email format?

Minus sign iconPlus sign iconSyntheX's email format typically follows the pattern of . Find more SyntheX email formats with LeadIQ.

How much funding has SyntheX raised to date?

Minus sign iconPlus sign icon As of September 2024, SyntheX has raised $5.2M in funding. The last funding round occurred on Dec 29, 2023 for $5.2M.

When was SyntheX founded?

Minus sign iconPlus sign iconSyntheX was founded in 2016.
SyntheX

SyntheX

Biotechnology ResearchCalifornia, United States11-50 Employees

SyntheX uses synthetic biology to create the next generation of drug discovery platforms. Using genetically engineered circuits, we rely on intracellular drug selection as opposed to in-vitro screening. This allows us to discover unbiased compounds with novel modes of action that can engage targets in either competitive or allosteric ways. We have developed ToRPPIDO to discover disruptors of protein-protein interactions (PPIs), and ToRNeDO to discover functional molecular glues for degraders of a neosubstrate of interest with a desired E3 ligase. 
In the same cells, we incorporate our proprietary DNA-encoded libraries of peptides and macrocycles to enable the production and selection of molecules in an efficient and high throughput manner. 
Our lead programs focus on oncology.

Section iconCompany Overview

Headquarters
409 Illinois St San Francisco, California 94158 US
Phone number
+1-415-706-8701
Website
synthexlabs.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $5.2M

    SyntheX has raised a total of $5.2M of funding over 6 rounds. Their latest funding round was raised on Dec 29, 2023 in the amount of $5.2M.

  • $10M

    SyntheX's revenue is in the range of $10M

Section iconFunding & Financials

  • $5.2M

    SyntheX has raised a total of $5.2M of funding over 6 rounds. Their latest funding round was raised on Dec 29, 2023 in the amount of $5.2M.

  • $10M

    SyntheX's revenue is in the range of $10M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.